Evidence map›Paper›PMID 27166630›Full record

ArticlePLoS genetics2016

BOD1 Is Required for Cognitive Function in Humans and Drosophila.

Sahar Esmaeeli-Nieh, Michaela Fenckova, Iain M Porter, M Mahdi Motazacker, Bonnie Nijhof, Anna Castells-Nobau, Zoltan Asztalos, Robert Weißmann, Farkhondeh Behjati, Andreas Tzschach and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Upregulated inwardly rectifying KJournal of biomedical research · 2025
    Article
  6. The gain-of-function UBE3AScientific reports · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 5 countries.

Sahar Esmaeeli-NiehDepartment for Human Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Michaela FenckovaDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, Netherlands.
Iain M PorterCentre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee, United Kingdom.
M Mahdi MotazackerDepartment for Human Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Bonnie NijhofDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, Netherlands.
Anna Castells-NobauDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, Netherlands.
Zoltan AsztalosDepartment Genetics, Aktogen Limited, University of Cambridge, Cambridge, United Kingdom.
Robert WeißmannDepartment of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany.
Farkhondeh BehjatiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Andreas TzschachDepartment for Human Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Ute FelborDepartment of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany.
Harry ScherthanDepartment for Human Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Seyed Morteza SayfatiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
H Hilger RopersDepartment for Human Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Kimia KahriziGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Hossein NajmabadiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Jason R SwedlowCentre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee, United Kingdom.
Annette SchenckDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, Netherlands.
Andreas W KussDepartment of Human Genetics, University Medicine Greifswald and Interfaculty Institute of Genetics and Functional Genomics, University of Greifswald, Greifswald, Germany.
Max Planck Institute for Molecular Genetics · DEUniversity of Social Welfare and Rehabilitation Sciences · IRRadboud University Medical Center · NLUniversitätsmedizin Greifswald · DEUniversity of Dundee · GBRadboud University Nijmegen · NLUniversität der Bundeswehr München · DEUniversität Greifswald · DEUniversity of Cambridge · GB

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
Drosophila Transgenic RNAi Resource ProjectR01GM084947 · NIGMS · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2008 to 2019
$9.8M
Biotechnology and Biological Sciences Research Council BB/H013024/1NIGMS NIH HHS R01 GM084947NIH HHS P40 OD018537Wellcome Trust 067433/Z/02/ZWellcome Trust 095931
6 · The paper itself

Abstract

Here we report a stop-mutation in the BOD1 (Biorientation Defective 1) gene, which co-segregates with intellectual disability in a large consanguineous family, where individuals that are homozygous for the mutation have no detectable BOD1 mRNA or protein. The BOD1 protein is required for proper chromosome segregation, regulating phosphorylation of PLK1 substrates by modulating Protein Phosphatase 2A (PP2A) activity during mitosis. We report that fibroblast cell lines derived from homozygous BOD1 mutation carriers show aberrant localisation of the cell cycle kinase PLK1 and its phosphatase PP2A at mitotic kinetochores. However, in contrast to the mitotic arrest observed in BOD1-siRNA treated HeLa cells, patient-derived cells progressed through mitosis with no apparent segregation defects but at an accelerated rate compared to controls. The relatively normal cell cycle progression observed in cultured cells is in line with the absence of gross structural brain abnormalities in the affected individuals. Moreover, we found that in normal adult brain tissues BOD1 expression is maintained at considerable levels, in contrast to PLK1 expression, and provide evidence for synaptic localization of Bod1 in murine neurons. These observations suggest that BOD1 plays a cell cycle-independent role in the nervous system. To address this possibility, we established two Drosophila models, where neuron-specific knockdown of BOD1 caused pronounced learning deficits and significant abnormalities in synapse morphology. Together our results reveal novel postmitotic functions of BOD1 as well as pathogenic mechanisms that strongly support a causative role of BOD1 deficiency in the aetiology of intellectual disability. Moreover, by demonstrating its requirement for cognitive function in humans and Drosophila we provide evidence for a conserved role of BOD1 in the development and maintenance of cognitive features.

Indexed as

CognitionAnimalsCell Cycle ProteinsChromosome SegregationDrosophilaFibroblastsGene Expression RegulationGene Knockdown TechniquesHeLa CellsHumansLearningMiceMitosisNeuronsPolo-Like Kinase 1Protein Phosphatase 2Bod1 protein, humanCell Cycle ProteinsPolo-Like Kinase 1Protein Phosphatase 2Protein Serine-Threonine KinasesProto-Oncogene Proteins

Identifiers

PMID27166630
PMCPMC4864283
OpenAlexW2358452758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.